{"id":"W2264090971","doi":"10.1016/j.kint.2015.11.026","title":"Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome","year":2016,"lang":"en","type":"article","venue":"Kidney International","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":294,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"Alexion Pharmaceuticals; American Society of Nephrology","keywords":"Eculizumab; Atypical hemolytic uremic syndrome; Medicine; Intensive care medicine; Thrombotic microangiopathy; Internal medicine; Immunology; Complement system; Antibody; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003670318,0.0001357674,0.0001555036,0.0001430478,0.00003357103,0.000008570642,0.0001136313,0.00005930532,0.001425213],"category_scores_gemma":[0.00009650228,0.00008317413,0.0000361435,0.00005265942,0.00005826918,0.00007588562,0.00005486209,0.00004285479,0.0003141193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002790536,"about_ca_system_score_gemma":0.00007009646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000249583,"about_ca_topic_score_gemma":0.00001072789,"domain_scores_codex":[0.9992579,0.00006986714,0.0001758176,0.0002682075,0.00005948158,0.0001686907],"domain_scores_gemma":[0.9995704,0.0001479197,0.00006693497,0.0001172147,0.00005043056,0.0000470934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005193329,0.0003302562,0.9917461,0.00001074318,0.0001817903,0.00001364916,0.0001141353,1.484592e-7,0.0003373209,0.0001789521,0.004778625,0.001788964],"study_design_scores_gemma":[0.007820252,0.0004397184,0.9849912,0.00009689991,0.00004732649,0.00004564941,0.000008072428,0.000001433877,0.0004091501,0.00011578,0.005896087,0.0001284299],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971254,0.00009302138,0.00003217079,0.001061103,0.0003378424,0.0004849712,0.0004083549,0.00002114148,0.0004360204],"genre_scores_gemma":[0.9987528,0.00001396013,0.00002529397,0.0001732387,0.00002418829,0.0001233309,0.0001353606,0.000009025242,0.0007428306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007300919,"threshold_uncertainty_score":0.9994876,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004381832449226359,"score_gpt":0.2181620525448668,"score_spread":0.2137802200956405,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}